多发性骨髓瘤衍生的细胞外囊通过T细胞耗尽的免疫抑制作用
Shinya Hagiwara1, Masaki Ri1,2, Toru Ebina1
1Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan.
Cancer science
|May 9, 2025
概括
多发性骨髓瘤 (MM) 细胞外囊泡 (EVs) 通过增加免疫检查点标记物来抑制T细胞活性. 这有助于免疫抑制瘤环境,损害抗癌免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 细胞外囊泡 (EVs) 在瘤进展中发挥作用,包括多发性骨髓瘤 (MM) 的血管生成和耐药性.
- 来自MM的EVs在调节免疫系统,特别是T细胞枯竭的功能仍然很不清楚.
研究的目的:
- 研究MM衍生的EVs对T细胞耗尽标记物的影响.
- 为了确定MM EVs中的特定蛋白质,这些蛋白质有助于免疫抑制.
主要方法:
- 来自MM衍生的EVs的健康捐赠者的活化外周血液单核细胞 (PBMC) 的治疗.
- 对CD8+T细胞上免疫检查点标记体的表达的分析.
- 对MM衍生的EV进行蛋白质组分析.
主要成果:
- 来自MM的EV诱导了免疫抑制作用,上调了CD8+T细胞上的免疫检查点标记物.
- 蛋白质组分析揭示了与T细胞疲劳和炎症相关的IL-8,SLC1A5,PIN2和FSP1等蛋白质.
- 在MM EVs中发现斯芬哥辛激酶1 (SPHK1) 富含,这表明它在SPHK1/S1P信号介导免疫抑制中的作用.
结论:
- 来自MM的EVs通过调高免疫检查点标记物来促进T细胞疲劳.
- 这些EVs有助于MM的免疫抑制微环境,导致T细胞活性下降.
- 准SPHK1/S1P信号可能是针对MM诱导的免疫抑制的潜在治疗策略.
更多相关视频
相关概念视频
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K


